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Introduction
The pandemic of the corona virus disease 2019 (CO-
VID-19) that started in Wuhan (China) in December 2019 
was caused by the severe acute respiratory syndrome coro-
navirus (SARS-CoV-2), and it has significantly endan-
gered the health of both healthy people and those with 
chronic diseases1-3 which, like the elderly, are at risk of 
developing a more severe form of the disease4.
The most common symptoms of COVID-19 are fever, 
dry cough, shortness of breath and tiredness. Some pa-
tients may also have muscle aches, runny nose, sore 
throat, nasal congestion, abdominal pain, vomiting or di-
arrhoea. Most infected people develop mild illness and it 
should be noted that some infected people have an asymp-
tomatic course1,2,5,6.This represents the most common pos-
sible route of further infection and the spread of the epi-
demic6.
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A B S T R A C T
The paper presents the guidelines made by the Multidisciplinary Team for Osteoporosis for patients in the General 
Hospital “Dr.Josip Benčević”, Slavonski Brod and general practitioners in the Brod-Posavina County in order to inform 
them properly about the COVID-19 pandemic and the recommendations of the National Civil Protection Committee, as 
well as to help them reduce their fear and to improve their cooperation with their general practitioners. A system of record-
ing new fractures in the county was maintained since the onset of the epidemic. The recommendations for patients with 
osteoporosis include their lifestyle, medical treatment and balanced nutrition, following the advices of the International 
Osteoporosis Foundation, the Croatian Osteoporosis Society and the British Royal Osteoporosis Society. Living with os-
teoporosis demands balanced nutrition, regular exercise and taking prescribed medications. As in the present conditions 
of COVID-19 epidemic outdoor physical activities are temporarily limited it is necessary to ensure the availability of 
calcium-rich food and vitamin D supplies. As medical treatment of osteoporosis does not increase risk of COVID-19 infec-
tion it is recommended for patients to continue their prescribed therapy in consultation with their general practitioner.
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The problems of people with osteoporosis have been 
neglected since the onset of the COVID-19 epidemic; pa-
tients find it harder to reach both family doctors and spe-
cialists. A large number of outpatient specialist and diag-
nostic procedures have been postponed. There is also a 
shortage of medical staff. The employment of staff in ra-
diological examinations and the treatment of patients af-
fected by the infectious disease has reduced the number 
of both first and control examinations, hindering the di-
agnosis and control of patients with all chronic diseases, 
including osteoporosis. 
In the General Hospital “Dr.Josip Benčević” in Slavon-
ski Brod in Croatia, the work at the endocrinology and 
physical medicine departments was reduced to 30%, which 
allowed only 1/3 of the patients to be treated. Individual 
cases of asymptomatic vertebral fractures have been treat-
ed automatically by a previously defined collaboration in 
the Multidisciplinary Team for Osteoporosis of the Gen-
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eral Hospital (MDTOP) which was established in the hos-
pital two years ago. The team consists of a radiologist, a 
traumatologist-orthopedist, an endocrinologist, a physical 
medicine specialist and two nurses from the endocrinol-
ogy and traumatology daily hospital who coordinate with 
the patients. Despite the established telephone line at the 
daily hospital, it was not possible to adequately control all 
patients so that a new set of instructions and recommen-
dations for osteoporotic patients in line with the current 
COVID-19 epidemic had to be developed by the team.
Osteoporosis
Osteoporosis (OP) is a condition of decreased bone den-
sity and strength which results in bones becoming brittle 
and prone to fracture7. The causes of osteoporotic fractures 
are numerous. Low bone mass in childhood due to reduced 
physical activity and inadequate nutrition results in low 
peak bone mass, which at an early age becomes mechani-
cally inadequate and prone to fracture8. Exposure to a 
number of risk factors such as: smoking, consumption of 
caffeine, alcohol, antiepileptics and corticosteroids, an-
orexia and early menopause are the most common rea-
sons7,8. Decreased levels of estrogen, androgens, growth 
hormone and other cellular regulators alter activity in the 
bone metabolic unit and ensure poor bone production8,9. 
Awareness of osteoporosis as a disease is underestimated 
and complications are severe8.
Prolonged life expectancy with reduced activity in-
creases the number of people with osteoporosis. Today 
about 250 million people suffer from osteoporosis, mostly 
women but also men7. According to the predictions of 
Melton et al. an increase in all types of fractures is ex-
pected, especially the hip, whose annual incidence is about 
1.7 million8. According to Cooper et al. the expected glob-
al number of hip fractures in 2050 will be around 5935 
millions9. This will bring significant economic costs of 
treatment of both the disease and complications. Hospital-
izations of osteoporotic complications are greater than the 
sum of hospitalizations for diabetes, acute heart attack, 
and malignancies10. Mortality from osteoporotic fractures 
ranks 4th among all causes of mortality and it is growing 
enormously despite all attempts to reduce economic costs, 
treatment efficiency, and improve quality of life with os-
teoporosis11.
Symptoms and signs of osteoporosis
There are no clinical signs of osteoporosis until frac-
tures happen; this is why many authors describe osteopo-
rosis as a silent disease. Therefore, any new fracture in 
individuals older than 50 years with or without recent 
trauma should raise clinical suspicion of osteoporosis10,11. 
The clinical suspicion is higher in the case of a fracture of 
the spine, hip, wrist or shoulder. Although the disease is 
more common in women, its incidence in men should not 
be underestimated11. 
Some patients might feel chronic pain which causes 
disability, sometimes the first complaint might be the loss 
of height caused by vertebral compression due to fracture, 
especially when they are multiple. Fractures that occur 
spontaneously or following minor trauma are called fragil-
ity fractures and are very common in osteoporotic indi-
viduals12.
Osteoporosis and COVID-19:  
Recommendations
The Multidisciplinary Team for Osteoporosis (MD-
TOP) of the General Hospital “Dr. Josip Benčević “ in Sla-
vonski Brod, Croatia has prepared recommendations for 
osteoporosis treatment during the COVID-19 pandemic 
for people with osteoporosis and for general practitioners 
in the Brod-Posavina County. Measures of physical activ-
ity, diet and prescribing therapy for osteoporosis are pro-
posed in accordance with the recommendations of the 
International Osteoporosis Foundation, the British Royal 
Osteoporosis Society and the Croatian Osteoporosis Soci-
ety12,13.
It is important to emphasize that patients with osteo-
porosis do not have an increased risk of COVID-19 infec-
tion12. Osteoporosis is mostly present in middle and old 
age, so patients belong to the category of persons with a 
higher risk to develop complications and they need a strict 
TABLE 1
GUIDANCE ON SEEKING MEDICAL HELP FOR OSTEOPOROTIC PATIENTS
•  If you are over 50, low weight, smoking, taking corticosteroids, asthma medications, epilepsy or have had a previous fracture 
you are at risk for osteoporosis.
•  If you have sudden back pain caused by lifting a load or spontaneously or if you become immobile – you cannot stand or walk, 
contact your family doctor who will refer you to closest hospital emergency department for radiological examination.
•  In case of emergency care it is advisable to stay in hospital treatment at Traumatology and Orthopaedics Department. Continu-
ation of medical care will be coordinated with all osteoporosis team members.
•  In other cases with X-ray findings, call the coordinator’s nurse for an appointment for densitometric measurement of bone 
density and examination by an endocrinologist.
•  For contactless examination submit A5 referral attached laboratory findings KKS, ast, alt, GGT, af, GUP, urea, creatinine, 
vitamin D3, osteocalcin and beta-crosslaps. 
•  After consulting an endocrinologist or physiatrist, you will receive instructions from the team coordinator to continue treatment.
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isolation in case of disease in the immediate vicinity. In 
addition to the recommendations of the National Civil Pro-
tection Committee on the implementation of hygienic mea-
sures, protection, isolation and staying at home are the 
main measures to be applied. Protection includes avoiding 
close contact with high-risk individuals for at least 10 
weeks. Social distance is important if there are persons 
with symptoms in the immediate vicinity, and staying at 
home is the best measure to prevent COVID-1912,14. Cau-
tion should be taken with shopping and all other daily 
activities. 
As hospitals and clinics tend to be overloaded and hard 
to reach, The Multidisciplinary Team for Osteoporosis 
(MDTOP) has provided guidance for osteoporotic patients 
specifying when and how they should seek medical help 
during the COVID-19 epidemic, as outlined in Table 1. 
They also included the following recommendations related 
to behaviour of osteoporotic patients during the COVID-19 
epidemic:
•  reduce social contacts, grouping, maintain a distance 
of 2 m
•  avoid contact with anyone who has respiratory prob-
lems
•  wash your hands regularly and thoroughly, use a 
disinfectant 
•  walk as far as possible in the fresh air
•  exercise as recommended by a physician
•  maintain a normal diet, with increased intake of 
foods rich in calcium and vitamin D.
•  take the prescribed medication as directed
•  consult your family doctor or specialist to discon-
tinue therapy
With regard to nutrition, particularly the regular in-
take of calcium and vitamin D, MDTOP listed in their 
brochure foods high in calcium (Table 2) and its recom-
mended daily amounts (Table 3) as well as the daily 
amounts of vitamin D (Table 4).
Therapy for Patients with Osteoporosis
Recommendations for the treatment of osteoporosis 
have been partially modified with respect to the emerging 
conditions of the pandemic. It is recommended to continue 
all previous therapies for the prevention and treatment of 
osteoporosis: Intake of calcium with food with additional 
substitution as before the epidemic (Tables 2 and 3). The 
same goes for vitamin D (Table 4)17–20. Analgetics should 
be taken as before pandemic. Despite notes on the adverse 
effects of ibuprofen in COVID-19 infection, there is cur-
rently no clear medical evidence17,18. It is recommended to 
replace it with paracetamol if there are no contraindica-
tions. Other non-steroid anti-inflammatory drugs can be 
taken if prescribed by a doctor.
Taking antiresorptive drugs can be continued without 
complications12,17,18. It is necessary to take care of the pre-
viously introduced method of taking the drug while main-
taining an upright position, consuming plenty of fluids. In 
case of sudden side effects, family doctor should be con-
sulted. Although it is known that COVID-19 infection can 
lead to an increased thrombotic risk, SERM-s therapy can 
also be continued without additional control if individuals 
do not have deep vein thrombosis, vasomotor symptoms 
and cramps that started before the epidemic12,17,18. In case 
of complicated COVID-19 infection, it should be abruptly 
discontinued with controlling coagulation parameters and 
TABLE 2
FOODS HIGH IN CALCIUM*
FOOD Serving size Calcium (mg)
Milk 200 ml 272
Yogurt 150 ml 210
Hard cheese   30 mg 245
Cow cheese 110 mg 142
Ice cream 110 mg 112
Cooked broccoli 110 mg   45
Spinach 110 mg 179
Sardines 100 mg 420
Salmon 100 mg   76
Bread 30 gr   53
*Modifed according to Food Standard Agency ( 2002)15
TABLE 3


















0–1 * Not specified
1-59 600 IU/day Not specified
60–70 600 IU/day 800–1000 IU/ day 
71+ 800 IU/day 800–1000 IU/ day
Targeted value
25(OH)D 
50 nmol/l for healthy 
persons of all ages
75 nmol/l for 
preventing falls and 
fractures
* minimal intake 400 IU/ day
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monitoring general condition. In milder cases of Covid-19 
infection, the therapy should not be discontinued18.
Therapy with teriparatide which is anabolic and en-
hances bone strength and reduces fractures has no con-
traindications for taking during the COVID-19 epidem-
ic12,17,18. It is important to ensure optimal calcium and 
vitamin D intake as before19,20. In case of inability to take 
the drug due to the current situation, therapy can be omit-
ted for a short time because it will not affect the overall 
bone status. Patients nearing the end of teriparatide ther-
apy should make an appointment with their family doctor 
to continue therapy.
Denosumab therapy - an antibody that slows bone deg-
radation and prevents fractures - must be continued dur-
ing the COVID 19 epidemic. Despite being a monoclonal 
antibody, denosumab does not suppress the immune sys-
tem and does not make it suitable for COVID-19 infection. 
No additional medication should be used to prevent infec-
tion when using denosumab. The necessity of taking it is 
pointed out in the COVID-19 guidelines from both NSHE 
and NICE12,17,18.
The same guidelines recommend continuous denosum-
ab therapy. Due to the possible situation of inability to 
procure the drug or the inability to administer denosum-
ab, the therapy should not be delayed for more than 4 
weeks to maintain the effectiveness of the drug and may 
be given 4 weeks earlier depending on individual circum-
stances. Therapy is given by the patient or family doctor 
(as in the previous administration of the drug). A tele-
phone consultation is possible if needed. Depending on the 
circumstances, zolendronate treatment may be discontin-
ued or postponed for a period of 6 months14,16. The effect of 
denosumab treatment ceases after 6 months after discon-
tinuation and another drug is usually prescribed to con-
tinue treatment19–23. With zolendronate, the effect can be 
observed for up to 12 months12,18,19. It is definitely neces-
sary to continue exercise and an optimal diet rich in cal-
cium and vitamin D20,21. It is possible to maintain the cur-
rent calcium and vitamin D therapy on the recom mendation 
of the doctor without checking the level of calcium in the 
blood. When applying zolendronate possible transient pain 
in the muscles of the body might occur accompanied by a 
mild temperature for which it is necessary to take 
paracetamol in a dose of 1000–2000 mg per day19. If symp-
toms persist for more than 3 days, a family physician 
should be consulted. All consultations should be conduct-
ed by telephone. At the end of the epidemic, a complete 
re-evaluation of the condition is required to decide further 
treatment.
Taking medications such as Alendor, Risbon and Iban-
dronate requires adherence to the instructions to deal 
with possible side effects of the digestive system and pos-
sibly pain in the bones, muscles and joints in venous forms. 
If the problems persist, a family doctor should be con-
sulted over the phone. In mild disorders, therapy should 
not be discontinued.
People on hormone replacement therapy must have 
regular mammograms and ultrasounds and consult a 
family doctor as needed.
Before the introduction of Raloxifene for the treatment 
of osteoporosis, it is necessary to make a complete coagu-
logram, cardiac and gynaecological treatment. Therapy 
should be discontinued in case of leg cramps, vasomotor 
problems or varicose veins in the legs.
Taking the above medications does not increase the 
risk of COVID-19 infection. Forteo teriparatide therapy 
has also not been associated with an increased risk of 
COVID-19 infection and should be continued as directed. 
Sufficient amounts of drug and needles for application 
should be provided.
Recommendations on Physical Activity
Exercise is very important for persons with osteoporosis 
as it maintains bone status, ensures muscle strengthening 
and reduces the possibility of falls and fractures. Every 
patient with a fracture must undergo the physical therapy 
for which he was educated during his stay in the hospital 
in order to increase muscle strength and coordination, as 
well as the possibility of self-care. Others are recommend-
ed to exercise daily at home to strengthen muscle strength 
and mobility: bending, sideways squats, squats and bone 
load exercises (jumping, dancing, weights, rope).
It is important to remember that physical activity is 
important at any age, especially the elderly. Strong mus-
cles preserve and carry bones and prevent fractures. In-
creasing muscle strength increases mobility, general ac-
tivity, and reduces the risk of fracture. The level of 
activity gradually increases and adjusts individually. 
Studies confirm the complementary effect of exercise on 
muscle strength and general status16,17. It is important to 
know how long to exercise to maintain muscle strength 
and power. Health status and mobility determine the 
level and intensity of exercise for both bone load and mus-
cle status. When diagnosing osteoporosis, all patients re-
ceive recommendations for the intensity, type and length 
of exercise.
In most people with osteoporosis, even in middle age, 
50% of normal daily activity is recommended, which in the 
current circumstances, includes light bouncing, jumping, 
brisk walking, or light running on a treadmill. The pres-
ence of a vertebral fracture also prevents moderate daily 
activity. Therefore a 20% of normal daily activity of lower 
intensity is recommended (minimally faster walking, 
minimal jumping). In case of weakness or inability to per-
form some efforts, the goal is to avoid prolonged sitting. It 
requires more frequent getting up and short-term stand-
ing with deep breathing for a few minutes every half an 
hour to 1 hour16,17.
Exercises that maintain powerful and strong bones in-
clude a combination of exercises with weights, jumps and 
muscle strengthening workout. A diversity of activity is 
good for the bones and it is achieved with different move-
ments, directions and speeds – in activities like dancing. 
Exercises to stimulate bone activity also include exercise 
with weight load, standing, fast walking, jumping, perform-
ing certain exercises from the fitness program at home.
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To maintain muscle strength for middle-aged and ear-
ly elderly people, a physical activity lasting 20 to 30 min-
utes with maximum load on the arms, legs and spine is 
recommended. Also it is recommended to gradually in-
crease the intensity of exercises and loads in series of 12 
procedures with 3 repetitions16. Each physical activity 
must be individualized depending on health status: age, 
comorbidities, and mobility. Based on his/her previous ex-
perience, a person assesses themselves.
Conclusion
People with osteoporosis are not more exposed to 
 COVID-19 infection due to their disease. Staying at home 
and applying social isolation measures are currently the 
most important decisions. Taking calcium-rich food to 
maintain bone density is essential during an epidemic. 
Calcium and vitamin D supplementation should also be 
taken if previously recommended.
Daily exercise according to age, comorbidities and gen-
eral status is necessary by keeping the intensity and form 
of exercise at home in the pre-epidemic range. It is neces-
sary to continue all the prescribed therapy for the treat-
ment of osteoporosis because it does not increase the risk 
of developing COVID-19 complications according to all 
guidelines. In the midst of the COVID-19 epidemic, it is 
certainly important to minimise all external daily activi-
ties. A newly formed fracture of the spine or any other bone 
requires physical activity in optimal shape taking into 
account the safety of performance the quality of life. Then 
it is necessary to consult a specialist and change the cur-
rent therapy.
The danger of the present moment has hindered the 
mutual “face to face” communication. Accordingly, the 
MDTOP team the “Josip Bencevic” Hospital in Slavonski 
Brod, prepared the modified recommendations of MDTOP 
during COVID-19 pandemic. Teams of nurses and physi-
cians are always available by phone to answer all patients 
questions and provide them with assistance every time 
they need it, especially about most common questions such 
as: How much and how to exercise at home, what medica-
tions to take and how, how to deal with complications of 
the disease: pain, immobility, etc. Hopefully, following the 
above critical guidance will help protect all older adults 
and those affected by osteoporosis vulnerable to the im-
pact of COVID-19.
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PREPORUKE ZA OBOLJELE OD OSTEOPOROZE I LIJEČNIKE OBITELJSKE MEDICINE U DOBA 
COVID-19 PANDEMIJE
S A Ž E T A K
Multidisciplinarni tim za osteoporozu (MDTOP) OB „Dr. Josip Benčević” Slavonski Brod pripremio je preporuke za 
postupanje u pandemiji COVID-19 za osobe sa osteoporozom i za liječnike obiteljske medicine u cilju smanjenja straha 
naših pacjenata i lakšu suradnju s liječnicima obiteljske medicine u novonastaloj situaciji. Pokušali smo zadržati i sistem 
evidentiranja novih prijeloma u tom periodu. Življenje s osteoporozom zahtijeva održavanje određenog načina prehrane, 
tjelovježbe i uzimanja propisane terapije. U sadašnjim uvjetima epidemije COVID-19 ograničava se privremeno tjelesna 
aktivnost u vanjskim uvjetima. Potrebno je uz mjere samoizolacije i socijalne distance osigurati opskrbu hranom bogatom 
kalcijem i vitaminom D. Lijekovi za liječenje osteoporoze ne povećavaju rizik oboljevanja od COVID-19 infekcije pa se 
preporuča nastaviti  propisanu terapiju uz konzultaciju sa svojim liječnikom. U preporukama je naglašen razmjer pan-
demije i moguće posljedice za oboljele od osteoporoze. Opisana je klinička slika i ponovljene preporuke Nacionalnog 
stožera civilne zaštite kako živjeti u doba pandemije. Predložene su mjere tjelesne aktivnosti, prehrane i propisivanja 
terapije za osteoporozu u skladu s preporukama Međunarodne fundacije za osteoporozu, Britanskog kraljevskog društva 
za osteoporozu i Hrvatskim smjernicama za osteoporozu. Liječnicima obiteljske medicine su poslane upute o monitori-
ranju terapije tijekom pandemije.
